Forty-seven feline and 60 canine epithelial tumors were studied to test the coordinate expression of cytokeratin 7 (CK 7) and cytokeratin 20 (CK 20) using commercially available monoclonal antibodies and an avidin-biotin immunoperoxidase staining technique. Previously, the distribution of both cytokeratins was examined in normal tissues from 4 cats and 4 dogs. The pattern of distribution of CK 7 in normal tissues was similar, with minor differences, to that described in humans, whereas the reactivity pattern of CK 20 in cats and dogs was wider than that in humans. The subset of tumors strongly expressing CK 7 and CK 20 included pancreatic adenocarcinomas (100%), transitional cell carcinomas (75%), and endometrial carcinomas (67%) in the cat. None of the canine tumors had this immunophenotype. Feline (50%) and canine (56%) mammary gland carcinomas and canine cholangiocarcinomas (67%) were the only tumors presenting the CK 7ϩ/CK 20Ϫ immunophenotype, whereas the CK 7Ϫ/CK 20ϩ immunophenotype included thyroid carcinomas (100%), intestinal adenocarcinomas (60%), bronchioloalveolar carcinomas (50%), and renal carcinomas (50%) in the cat and intestinal adenocarcinomas (56%), gastric adenocarcinomas (50%), and ovarian carcinomas (50%) in the dog. The CK 7Ϫ/CK 20Ϫ immunophenotype included the rest of the analyzed tumors. The immunohistochemical evaluation of coordinate expression of both CK 7 and CK 20 in feline and canine carcinomas using monoclonal antibodies provides important information that can help to discriminate among carcinomas from different primary sites and could be particularly helpful in the determination of the primary site of origin of carcinomas presenting as metastatic disease.
Cytokeratins (CKs), the intermediate filament proteins characteristically found in epithelium and epithelial tumors, comprise a family of at least 20 different polypeptides. 15, 18 These CKs are numbered consecutively 1-20, representing differences in molecular weight and isoelectric pH. 18 CKs 1-8 are the most basic (type II) and form a pair with a specific acidic (type I) CK counterpart (Nos. [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . 3, 18, 24 Expression of a subset of these 20 different CKs is more or less tissue specific, as suggested by electrophoresis and immunohistochemical studies using chain-specific monoclonal antibodies to individual CKs. 16, 24, 25 Most importantly, determination of the CK profile of a particular carcinoma is useful in the differential diagnosis of carcinomas; studies have shown that these tumours tend to recapitulate the CK profiles of tissues from which they arise. 2, 4, 5, 31 CK typing, therefore, can be of practical importance in analyzing tumors presenting as metastatic disease from clinically unknown primary sites of origin.
Of particular interest are CK 7 and the most recently described member of the CK family, CK 20. CK 7, a basic (type II) keratin, is found in the glandular epithelium of a wide variety of organs, such as lung, ovary, endometrium, and breast, but appears to be absent in gastrointestinal epithelium and the adenocarcinomas arising therefrom. 1, 21, 26, 27, 32 CK 7 and CK 8 (another type II polypeptide) are expressed with CKs 18 and 19 (two type I CKs.). 18 CK 20 , previously known as protein IT, is distantly related to other acidic (type I) keratins and exhibits a unique and relatively restricted range of tissue expression, especially when compared with the other CKs of simple epithelium (CKs 8, 18, and 19) . Moreover CK 20 is present in heterotypic complexes with the type II CK 8 in which it seems to compete with the other type I CKs, 18 and 19. 18 CK 20 is expressed principally in epithelia of and tumors derived from the gastrointestinal tract, urothelium, and Merkel cells. 13, [17] [18] [19] However, despite this apparent tissue-specific distribution, ectopic CK 20 expression in sporadic cases of carcinomas derived from normally CK 20-negative tissues, e.g., breast, lung, and endometrium, has been also noted. 17 The purpose of the present study was to determine the distribution of CKs 7 and 20 in normal tissues and in epithelial tumors from cats and dogs and to test the hypothesis that analysis of coordinate expression of these CKs would prove to be a more powerful diagnostic approach than the study of the individual CK expression in the carcinomas of both species using routinely processed, formalin-fixed, paraffin-embedded samples and commercially available monoclonal antibodies.
Materials and Methods

Tissue preparation
Healthy tissue samples. The tissue specimens were obtained from four cats and four dogs of different breed, age, and sex. The animals were euthanatized because of traffic accidents with multiple fractures and different neoplastic processes. Immediately after euthanasia, a small piece was taken from several tissues and organs (Table 1) , including skin, oral mucosa, tongue, tonsils, trachea and lung, esoph- ageal, gastric, and small and large intestinal walls, salivary glands, pancreas, liver, kidney, urether and urinary bladder, adrenal, pituitary, thyroid, parathyroid, and mammary glands, prostate, epidydimus and testis, vagina, uterus and ovary, spleen and lymph nodes, spinal cord, cerebellum and cerebrum, skeletal muscle, cardiac muscle, and adipose tissue. Tissue specimens were fixed in 10% buffered formalin for 20-24 hours, embedded in paraffin, cut at 3 m, and stained with hematoxylin and eosin (HE).
Tumor samples. One hundred four surgical specimens of feline and canine carcinomas (46 and 58, respectively) from various primary sites as well as three cases of malignant mesotheliomas (one feline and two canine) were retrieved from the archives of the Departments of Comparative Pathology at the University of Las Palmas de Gran Canaria and the University of Córdoba. The tumor tissue samples were submitted as surgical excision specimens in 10% buffered formalin. Fixation time, although uncertain, was probably 24-48 hours in most cases. Tumor samples were embedded in paraffin, and sections were cut at 3 m. Diagnoses ( Table 2) were confirmed by retrieval of pathology reports and review of HE-stained sections. 38
Antibodies
Two commercially available antibodies (Dako Corp., Carpinteria, CA) were used to analyze CKs 7 and 20 distribu-tion. OV-TL 12/30 is a monoclonal antibody developed against the OTN 11 ovarian carcinoma cell line. It has been characterized by immunoblotting and recognizes CK 7 as defined by a previously published classification method. 15 It was used at a dilution of 1 : 60. K S 20.8 is a monoclonal antibody developed against the cytoskeletal preparation isolated from microdissected villi of human duodenal mucosa. It has been characterized by immunoblotting and recognizes CK 20. 17 It was used at a dilution of 1 : 60.
Immunohistochemical staining
The avidin-biotin peroxidase complex (ABC) method (Vector Laboratories, Burlingame, CA) was used with both antibodies. Deparaffinized sections were incubated with 1% hydrogen peroxide in methanol for 30 minutes to block endogenous peroxidase activity. Predigestion of tissue sections for 10 minutes with 0.1% pronase (Sigma Chemical Co., St. Louis, MO) was employed according to the recommendations of the manufacturer for formalin-fixed tissue samples. Optimal concentration (0.1%) and incubation time (10 minutes) of pronase were determined at room temperature for feline and canine tissues. After proteolytic enzyme treatment, the slides were covered with 10% normal goat serum in phosphate-buffered saline (PBS) for 30 minutes before incubation with the primary antibodies for 18 hours at 4 C. Slides were incubated with the biotinylated rabbit anti- mouse immunoglobulin antibody (Dako) diluted 1 : 40 in PBS containing 1% normal goat serum for 30 minutes and with ABC for 60 minutes, both at room temperature. Between each step, slides were washed three times for 10 minutes in PBS. The chromogen, 0.5% 3,3Ј-diaminobenzidine tetrahydrochloride (Sigma) diluted 1 : 10 in 0.05 M Tris containing 0.3% of hydrogen peroxide, was applied to the slides for 1-2 minutes at 20-22 C. Slides were counterstained with Harris's haematoxylin. As negative controls, PBS and mouse ascitic fluid at the same dilution as the specific reagents was substituted for primary antibodies.
Multiple fields of each slide were examined, and the results were expressed in a semiquantitative fashion, according to the estimated percentage of positive cells (1-33% ϭ ϩ; 34-66% ϭ ϩϩ; 67-100% ϭ ϩϩϩ), based upon the consensus of at least two observers.
Results
Immunohistochemical reactivity in normal feline and canine tissues
The immunohistochemical results obtained for normal tissues using both monoclonal antibodies (MABs) are summarized in Table 1 . No major differences in staining patterns were observed within the four cats and within the four dogs with each of the two antibodies. Incubations of corresponding tissue specimens of each of the four cats and the four dogs with a particular antibody resulted in a similar staining reaction in these specimens with only minor differences. In all sections, only the epithelial and mesothelial cells were stained. Mesenchymal tissues were not stained. However, differences in staining pattern were noticed between the two antibodies employed.
In the skin, CK 7 MAB staining reaction was slightly stronger in cats and was restricted to acini and ducts of the apocrine glands and to acini of eccrine glands in both species. CK 20 MAB reacted only with solitary basal cells of the cutaneous epithelium, identified as Merkel cells because of the round morphology and basal location, and with acini and ducts of apocrine glands and acini of eccrine glands.
In the digestive system, CK 7 MAB stained acini and ducts of the salivary glands and anal sac glands. In addiction, this antibody reacted with the biliary epithelium and pancreatic ducts. A strong reaction with CK 20 MAB was observed in the taste buds of gustatory papillae (Fig. 1) , in Merkel cells of the oral cavity, in the gastric pits and corpus ( Fig. 2 ) and pyloric glands of the stomach, and in the surface epithelium, mucosal crypts, and Brunner's glands of the intestine in both species. The reactivity in the biliary epithelium was heterogeneous in the cat and more uniform in dog. Mesothelial cells were positive only with CK 7 MAB. In the respiratory system of both species, the reactivity of CK 7 MAB appeared in suprabasal ciliated columnar epithelium, in epithelium of respiratory bronchioles, in alveolar type II cells, and strongly in the mucosal glands. No structure was positive with CK 20 MAB in the respiratory system in the dog, but in the cat glandular structures and cylindrical ciliated epithelium showed a strong reaction, and solitary positive cells stained in the bronchiolar epithelium.
The staining patterns of the MABs in the urinary system were very similar in both species. Collecting ducts and Bowman's capsule reacted with both antibodies, with the exception of Bowman's capsule in dog, which did not react with CK 20 MAB. In the transitional epithelium, superficial cells were strongly and homogeneously positive with both antibodies in both species; however, basal cells showed reactivity only with CK 7 MAB.
In the endocrine glands, immunoreactivity was heterogeneous. In the feline pituitary gland, positivity was only seen with CK 20 MAB (Fig. 3) , whereas in the dog reactivity with CK 7 MAB was observed exclusively in cells of Rathke's pouch (Fig. 4) . The thyroid and parathyroid glands reacted weakly with both antibodies in the dog and only with CK 20 MAB in the cat, with a stronger reaction. The epithelial cells of adrenal gland did not stain with any of the MABs used.
In the male genital tract, immunoreactivity was observed in prostate with both antibodies, and there was patchy immunoreactivity in the epididymis of the dog with CK 20 MAB. In the female genital tract, CK 7 and CK 20 MABs reacted with some structures with the same intensity. The rete ovarii and the surface epithelium and glands in endometrium reacted with both antibodies, whereas the surface epithelium of the ovary showed reaction only with CK 7 MAB. Squamous epithelium in the vagina was unreactive.
In the mammary gland, feline and canine luminal secretory cells reacted with CK 7 MAB, and the canine cells reacted also with CK 20 MAB. Myoepithelial cells did not react and ductal structures showed high intensity with CK 7 MAB. CK 20 MAB reacted with the epithelial cells in the ducts in dogs and only in solitary cells, in basal localization of ectatic ducts, in cats.
Ependymal cells were not stained by either of the antibodies used.
Immunohistochemical reactivity in feline and canine tumors
A total of 107 feline and canine tumors (47 and 60, respectively) from various sites of origin were evaluated for immunoreactivity with MABs against CK 7 (OV-TL 12/30) and CK 20 (K S 20.8). The results are summarized according to primary sites of tumor in Table 2. Marked differences in the coordinate expression of CK 7 and CK 20 were apparent between both species and among tumors from different primary sites. Tumors could be subcategorized into four groups according to corresponding CK 7 and CK 20 immunophenotypes (Table 3 ).
In the cats, tumors of several sites frequently had a CK 7ϩ/CK 20ϩ immunophenotype, including pancreatic adenocarcinoma (100%), transitional cell carcinoma (75%) (Figs. 5, 6 ), and endometrial carcinoma (67%). In contrast, 50% of mammary gland carcinomas ( Fig. 7) showed a predominant CK 7ϩ/CK 20Ϫ immunophenotype. Other carcinomas were characterized by a CK 7Ϫ/CK 20ϩ immunophenotype, including thyroid carcinoma (100%), intestinal adenocarcinoma (60%), bronchioloalveolar carcinoma (50%), and renal carcinoma (50%). Gastric adenocarcinoma (100%), malignant mesothelioma (100%), hepatocellular carcinoma (67%), mammary gland carcinoma (50%), and renal carcinoma (50%) had a CK 7Ϫ/CK 20Ϫ immunophenotype.
In dogs, the CK 7ϩ/CK 20Ϫ immunophenotype was exhibited by cholangiocarcinoma (67%) ( Fig. 8 ) and mammary gland carcinoma (56%), whereas intestinal adenocarcinoma (56%) ( Fig. 9 ), gastric adenocarcinoma (50%), and ovarian carcinoma (50%) (Fig. 10) showed a CK 7Ϫ/CK 20ϩ immunophenotype. The majority of the tumors analyzed in dogs had CK 7Ϫ/ CK 20Ϫ immunophenotype. This group included hepatocellular carcinoma (100%), pancreatic adenocarcinoma (100%), malignant mesothelioma (100%), renal carcinoma (100%), bronchioloalveolar carcinoma (100%), endometrial carcinoma (66%), gastric adenocarcinoma (50%), transitional cell carcinoma (50%), and prostatic adenocarcinoma (50%). No canine tumors showed the CK 7ϩ/CK 20ϩ immunophenotype, in contrast with feline tumors.
Discussion
Determination of the site of metastatic carcinomas using examination of routine HE-stained slides continues to present diagnostic challenges for the pathologist. Immunohistochemical approaches using antibodies against various CKs have often been employed to narrow the diagnostic possibilities. The family of CKs has been characterized as a group of intermediate filaments comprised of at least 20 related polypeptides. 15, 18 Both biochemical and immunochemical studies subsequently elucidated the tissue-specific distribution of CKs in various epithelia, and it was soon recognized that tumors arising from a given epithelium generally preserved this pattern of CK expression despite malignant transformation. This phenomenon has therefore allowed the use of chain-specific MABs against individual CKs in the differential diagnosis of carcinomas from various primary sites in humans 1, 3, 4, 6, 20 and to a lesser extent in dogs [33] [34] [35] and cats. 8, 12 The aim of the current study was to focus on two members of the CK family, CK 7 and CK 20, and to assess their patterns of coordinate expression in normal feline and canine tissues and in a variety of carcinomas in both species.
The feline and canine tissues were immunoreactive with highly specific MABs against human CKs, and this immunoreactivity was confined to epithelial and mesothelial cells, confirming the broad interspecies cross-reactivity of intermediate filament antibodies. 8, 12, [33] [34] [35] CK 7, a 54-kd polypeptide, was originally found to be distributed in a wide variety of simple epithelia, collecting ducts of the kidney, and bladder transitional cell epithelium and mesothelium in humans. However, it was absent in gastrointestinal epithelia, hepatocytes, proximal and distal tubules of the kidney, and squamous cell epithelia. 15, 26, 32 In the present study, the pattern of distribution of CK 7 in normal tissues from cats and dogs was similar, with minor differences, to that previously described in humans 26, 32 and dogs. 33, 34 CK 20, however, is a newly described 46-kd polypeptide distantly related to other acidic CKs. 18 This unique CK, originally discovered in human intestinal epithelium, was subsequently identified only in a restricted subset of epithelia, such as gastric pit cells, superficial urothelial cells, taste buds of the tongue, and Merkel cells of the epidermis. 18 In the present study, the reactivity pattern of CK 20 in cats and dogs was wider, and strong immunoreactivity for this CK was observed throughout apocrine and eccrine glands of the skin, in the surface epithelium and glands of the endometrium, and in collecting ducts of the kidney. Heterogeneous immunoreactivity for CK 20 was seen in acinar and ductal cells of the salivary glands, in the bile duct epithelium, and in the ductal epithelium of the mammary gland and thyroid and parathyroid glands. In the feline tissues, this CK was also seen in scattered hepatocytes, in the ciliated columnar epithelium of the airways (associated with a strong reaction of the mucosal glands), in Bowman's capsule of the kidney, in the pituitary gland, and in the rete ovarii. These differences from the results published for humans can be attributed to interspecies differences in the actual distribution pattern of CK 20; this CK is exceptional in its lack of immunologic cross-reactivity with other type I CKs, and it is only distantly related to the other CKs. 17, 18, 23 The pattern of distribution of CK 7 in feline and canine epithelial tumors was basically similar to that described in human carcinomas. 27, 32, 36 The expression of this CK was wider in feline tumors, and some differences between feline and canine carcinomas were observed. However, the spectrum of tumors positive for CK 20 in the present study was similar to that described in humans. 13, 17, 36, 37 In the present study, close correlation was found in CK 20 expression between feline and canine tumors and their corresponding normal epithelial tissues.
In addition to the tissue-specific profiles of CK expression in epithelial tumors, the coordinate expression of particular sets of cytokeratins has also been used to increase the sensitivity and discriminating power of CK expression as an aid in the diagnosis of undifferentiated tumors. 22, 29, 36, 37 In particular clinical settings, following determination of the CK 7/CK 20 profile, the differential diagnosis can often be narrowed to one or two possibilities; further narrowing of diagnostic possibilities is generally provided by morphologic examination and results of additional immunohistochemical studies. 9, 10 In the present study, most if not all tumors could easily be subclassified into one predominant category among the four expression profiles with respect to CK 7 and CK 20 immunoreactivity, although differences were observed between feline and canine carcinomas (Table 3 ).
In the cat, the CK 7ϩ/CK 20ϩ immunophenotype includes pancreatic adenocarcinomas (100%), transitional cell carcinomas (75%), and endometrial carcinomas (67%). However, none of the canine tumors had this immunophenotype (Table 3 ). CK 7 15, 17, 32 and CK 20 17 have been previously described in pancreatic adenocarcinomas. Coexpression of both CKs reported in human pancreatic adenocarcinomas was considered evidence for a ductal origin of these tumors. 36 Tran-sitional cell carcinomas of humans are characterized by the expression of CK 7 27, 32, 36 and CK 20, 7, 15, 17 as observed here in the feline tumors. In the dog, 50% of transitional cell carcinomas had a CK 7Ϫ/CK 20Ϫ immunophenotype, but the rest of the cases expressed CK 7, which was present in basal cells of normal canine transitional epithelium, as previously reported. 34 Sixty-seven percent of the feline endometrial carcinomas showed the CK 7ϩ/CK 20ϩ immunophenotype, in accordance with the results observed in the normal feline endometrium. The presence of CK 20 in human endometrial carcinomas is considered aberrant expression, 17, 36 whereas CK 7 is more frequently expressed in these tumors. 27, 32, 36 Feline (50%) and canine (56%) mammary gland carcinomas and canine cholangiocarcinomas (67%) were the only tumors with a CK 7ϩ/CK 20Ϫ immunophenotype (Table 3 ). Homogeneous reactivity for CK 7 has been described in normal glandular epithelium of mammary gland in humans, 17, 22, 26, 30 dogs, 35 and cats, 8 and heterogeneous reactivity has been described in mammary carcinomas. 8, 15, 22, 27, 30, 32, 35, 36 In addition, immunoreactivity with the same CK 20 MAB used in this study has been observed in human mammary gland carcinomas in association with CK 7 expression, 36 but this coexpression was not confirmed in the present study. However, normal canine mammary gland tissues expressed CK 20 heterogeneously. CK 7 immunoreactivity in canine cholangiocarcinomas was in accordance with previous reports in humans, 27 but contrary to other reports, 17 CK 20 expression was not observed in the canine samples. On the contrary, CK 20 expression was observed in feline cholangiocarcinomas, which exhibited the most variable CK 7/CK 20 immunophenotype among all tumors analyzed and should therefore always be included in the differential diagnosis of cancer from an unknown primary site in the appropiate clinical setting.
The CK 7Ϫ/CK 20ϩ immunophenotype included thyroid carcinomas (100%), intestinal adenocarcinomas (60%), bronchioloalveolar carcinomas (50%), and renal carcinomas (50%) in the cat and intestinal adenocarcinomas (56%), gastric adenocarcinomas (50%), and ovarian carcinomas (50%) in the dog. The expression of CK 20, with complete absence of CK 7 immunoreactivity, in all feline thyroid carcinomas analyzed reflects the immunophenotype of the normal thyroid gland in the cat. This findings contradicts previous reports in which only CK 7 expression was described in these tumors. 26, 32 Immunoreactivity with CK 20 antibodies is either lacking 13 or restricted to the neuroendocrine medullary carcinomas. 29 The expression of CK 20 has been identified in tumors arising in the gastrointestinal tract. 11, 13, 17, 18, 28, 36, 37 This widespread expression was corroborated here; 80% of feline intestinal adenocarcinomas and 56% of canine intestinal adenocarcinomas expressed CK 20. The expression of this CK in gastric adenocarcinomas was more heterogeneous. Fifty percent of the canine cases and none of the feline cases analyzed showed immunoreactivity in accordance with previous reports in humans. 13, 17, 36, 37 CK 7 expression is still more heterogeneous in tumors of gastric and intestinal origin. 15, 32, 36, 37 Bronchioloalveolar and renal carcinomas are characterized by the presence of CK 7 and the absence of CK 20 in humans, 11, 14, 15, 27 corresponding with the pattern of expression in normal human structures, although CK 20 has been also described in the bronchiolar epithelium. 17, 18 In the present study, the immunophenotype of these two types of tumors, together with thyroid carcinomas, was comparable with the immunophenotype of the corresponding normal structures. Canine ovarian carcinomas had the CK 7Ϫ/CK 20ϩ immunophenotype, although they showed also CK 7 expression in the remaining 50% of the cases not included in the CK 7Ϫ/CK 20ϩ category. These data are closer to those described in adenocarcinomas in the ovary in women. 27, 31, 36, 37 The CK 7Ϫ/CK 20Ϫ immunophenotype includes the rest of the analyzed tumors (Table 3) , but as in all immunohistochemical studies of tumors employing formalin-fixed, paraffin-embedded tissue specimens, one should be cautious in equating absence of immunostaining with absence of protein expression. Although corroborative immunohistochemical studies on frozen sections and biochemical analyses have not been performed, the present data correlate with those of previously reported studies 17, 27, 36 and with the findings in corresponding normal tissues of cats and dogs.
The immunohistochemical evaluation of coordinate expression of CKs 7 and 20 in feline and canine carcinomas using MABs provides important information that can help discriminate between carcinomas from different primary sites and could be particularly helpful in the determination of the site of origin of carcinomas presenting as metastatic disease.
